AIA-CL300

AIA-CL300

Instruments

Information

The AIA-CL300 enhances your clinical laboratory capabilities and resources. The AIA-CL300 is the ideal small immunoassay analyser to solve your specific needs and improve your laboratory and diagnostic efficiency. This innovative desktop automatic analyser meets the needs from small to large laboratories, to perform routine analysis, cover emergency use, run specific pathologies and esoteric tests. The AIA-CL300 benefits from the excellence and the unique technology of the AIA-CL range which have already made their proof in terms of ease of use, reliability, and analytical performance.
Tosoh International DMC BranchZ4.C20Tosoh Bioscience-Diagnostics is part of the Specialty division of Tosoh Corporation, a multi-national chemical company, present in 140 countries, employing 12,000 people. It is an acknowledged global leader in the diagnostic market and field of liquid chromatography. Tosoh has throughout the years demonstrated technological leadership in Immunochemistry, HPLC-based diabetes and Thalassemia screening as well as molecular testing solutions. These support the diagnosis and monitoring of life-threatening disease as diabetes, certain cancers and infections diseases among many others.  At the EuroMedLab 2023 Tosoh will launch the AIA®-CL300, its new Automated Chemiluminescent Enzyme Immunoassay Analyzer. This “Small Giant” is a flexible solutions to meet laboratories’ and hospitals’ specific needs. With its new design and compactness, AIA-CL300 sets new standards in terms of usability and result precision leading to better patient outcomes and treatments. The AIA-CL300 adds-on to the existing Tosoh Immunoassay Analyzer range, widely known for their reliability and analytical performance.

Join the event!